Ben Ruscigno

Ben Ruscigno is an experienced Immunology Sales Specialist at Aurinia Pharmaceuticals Inc., responsible for educating healthcare professionals about undiagnosed Lupus Nephritis and launching Lupkynis for adult patients in Brooklyn and Staten Island. Prior to this role, Ruscigno spent over a decade at Amgen, where responsibilities ranged from selling Parsabiv for secondary hyperparathyroidism to promoting Enbrel for various inflammatory conditions and launching Prolia for post-menopausal osteoporosis. Ruscigno also held positions at Novartis and Merck, focusing on the distribution of Reclast and other notable therapies. Educational background includes a Doctor of Osteopathic Medicine from New York College of Osteopathic Medicine and a Bachelor of Science in Biology from Wagner College.